Journey Free Cash Flow Per Share vs Ev To Sales Analysis

DERM Stock

USD 5.44 0.28 5.43%

Journey Medical financial indicator trend analysis is infinitely more than just investigating Journey Medical Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Journey Medical Corp is a good investment. Please check the relationship between Journey Medical Free Cash Flow Per Share and its Ev To Sales accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Free Cash Flow Per Share vs Ev To Sales

Free Cash Flow Per Share vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Journey Medical Corp Free Cash Flow Per Share account and Ev To Sales. At this time, the significance of the direction appears to have no relationship.

The correlation between Journey Medical's Free Cash Flow Per Share and Ev To Sales is 0.0. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Journey Medical Corp, assuming nothing else is changed. The correlation between historical values of Journey Medical's Free Cash Flow Per Share and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Journey Medical Corp are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Free Cash Flow Per Share i.e., Journey Medical's Free Cash Flow Per Share and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Journey Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Journey Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Journey Medical's Selling General Administrative is very stable compared to the past year. As of the 11th of December 2024, Sales General And Administrative To Revenue is likely to grow to 3.97, while Tax Provision is likely to drop about 102.6 K.

	2021	2022	2023	2024 (projected)
Interest Expense	7.0M	2.0M	1.7M	1.6M
Depreciation And Amortization	2.6M	4.4M	3.9M	4.0M

Interest Expense Depreciation And Amortization

Journey Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.78	0.49	0.49	0.48	0.92	-0.14	0.2	-0.83	0.05	0.9	-0.11	0.55	0.99	-0.59	0.31	0.66	0.12	0.8	0.54	0.88	0.78	0.98	0.24	-0.62	0.87
Short Long Term Debt Total	0.78		0.42	0.41	0.29	0.89	-0.03	0.34	-0.82	0.14	0.63	-0.51	0.58	0.84	-0.14	0.19	0.89	0.37	0.69	0.75	0.95	0.68	0.85	0.15	-0.48	0.72
Other Current Liab	0.49	0.42		0.94	-0.3	0.57	-0.09	0.3	-0.49	0.41	0.65	-0.72	-0.21	0.57	0.0	-0.14	0.71	0.8	0.65	0.43	0.55	0.77	0.61	0.61	0.2	0.02
Total Current Liabilities	0.49	0.41	0.94		-0.23	0.53	-0.24	0.21	-0.46	0.67	0.64	-0.64	-0.2	0.55	0.07	-0.15	0.67	0.75	0.58	0.49	0.54	0.72	0.6	0.77	0.3	0.02
Total Stockholder Equity	0.48	0.29	-0.3	-0.23		0.28	-0.3	-0.6	-0.03	-0.33	0.31	0.49	0.22	0.4	-0.33	0.35	-0.1	-0.54	-0.12	0.07	0.19	-0.17	0.36	-0.01	-0.67	0.66
Property Plant And Equipment Net	0.92	0.89	0.57	0.53	0.28		-0.04	0.43	-0.9	0.13	0.74	-0.35	0.53	0.93	-0.36	0.24	0.85	0.39	0.84	0.77	0.96	0.83	0.95	0.23	-0.49	0.76
Current Deferred Revenue	-0.14	-0.03	-0.09	-0.24	-0.3	-0.04		0.31	-0.06	-0.28	-0.13	-0.14	0.25	-0.1	0.1	0.59	0.02	0.02	0.11	-0.08	-0.03	0.02	-0.1	-0.32	-0.28	-0.05
Net Debt	0.2	0.34	0.3	0.21	-0.6	0.43	0.31		-0.68	0.21	0.08	-0.36	0.54	0.23	-0.17	-0.06	0.54	0.44	0.69	0.45	0.5	0.64	0.27	-0.17	0.04	0.15
Retained Earnings	-0.83	-0.82	-0.49	-0.46	-0.03	-0.9	-0.06	-0.68		-0.18	-0.71	0.34	-0.74	-0.85	0.49	-0.15	-0.82	-0.32	-0.95	-0.66	-0.94	-0.91	-0.87	-0.1	0.44	-0.73
Accounts Payable	0.05	0.14	0.41	0.67	-0.33	0.13	-0.28	0.21	-0.18		0.09	-0.39	-0.14	0.06	0.41	-0.18	0.34	0.52	0.17	0.45	0.21	0.3	0.13	0.69	0.61	-0.22
Cash	0.9	0.63	0.65	0.64	0.31	0.74	-0.13	0.08	-0.71	0.09		-0.23	0.32	0.92	-0.57	0.21	0.58	0.17	0.77	0.29	0.73	0.79	0.91	0.35	-0.45	0.66
Non Current Assets Total	-0.11	-0.51	-0.72	-0.64	0.49	-0.35	-0.14	-0.36	0.34	-0.39	-0.23		0.15	-0.26	-0.46	0.22	-0.77	-0.88	-0.38	-0.49	-0.46	-0.48	-0.31	-0.42	-0.28	0.2
Non Currrent Assets Other	0.55	0.58	-0.21	-0.2	0.22	0.53	0.25	0.54	-0.74	-0.14	0.32	0.15		0.52	-0.54	0.35	0.35	-0.28	0.59	0.33	0.62	0.45	0.49	-0.4	-0.66	0.79
Cash And Short Term Investments	0.99	0.84	0.57	0.55	0.4	0.93	-0.1	0.23	-0.85	0.06	0.92	-0.26	0.52		-0.52	0.27	0.74	0.22	0.83	0.56	0.91	0.82	1.0	0.26	-0.59	0.83
Net Receivables	-0.59	-0.14	0.0	0.07	-0.33	-0.36	0.1	-0.17	0.49	0.41	-0.57	-0.46	-0.54	-0.52		-0.12	0.01	0.42	-0.52	0.11	-0.32	-0.43	-0.47	0.23	0.62	-0.67
Good Will	0.31	0.19	-0.14	-0.15	0.35	0.24	0.59	-0.06	-0.15	-0.18	0.21	0.22	0.35	0.27	-0.12		0.0	-0.23	0.14	-0.02	0.16	0.03	0.25	-0.22	-0.55	0.42
Common Stock Shares Outstanding	0.66	0.89	0.71	0.67	-0.1	0.85	0.02	0.54	-0.82	0.34	0.58	-0.77	0.35	0.74	0.01	0.0		0.72	0.77	0.82	0.91	0.81	0.78	0.35	-0.16	0.42
Short Term Investments	0.12	0.37	0.8	0.75	-0.54	0.39	0.02	0.44	-0.32	0.52	0.17	-0.88	-0.28	0.22	0.42	-0.23	0.72		0.4	0.6	0.41	0.51	0.29	0.56	0.43	-0.27
Non Current Liabilities Total	0.8	0.69	0.65	0.58	-0.12	0.84	0.11	0.69	-0.95	0.17	0.77	-0.38	0.59	0.83	-0.52	0.14	0.77	0.4		0.53	0.87	0.98	0.84	0.14	-0.34	0.61
Other Current Assets	0.54	0.75	0.43	0.49	0.07	0.77	-0.08	0.45	-0.66	0.45	0.29	-0.49	0.33	0.56	0.11	-0.02	0.82	0.6	0.53		0.78	0.56	0.62	0.47	-0.12	0.4
Other Stockholder Equity	0.88	0.95	0.55	0.54	0.19	0.96	-0.03	0.5	-0.94	0.21	0.73	-0.46	0.62	0.91	-0.32	0.16	0.91	0.41	0.87	0.78		0.85	0.93	0.24	-0.46	0.74
Total Liab	0.78	0.68	0.77	0.72	-0.17	0.83	0.02	0.64	-0.91	0.3	0.79	-0.48	0.45	0.82	-0.43	0.03	0.81	0.51	0.98	0.56	0.85		0.84	0.29	-0.2	0.51
Total Current Assets	0.98	0.85	0.61	0.6	0.36	0.95	-0.1	0.27	-0.87	0.13	0.91	-0.31	0.49	1.0	-0.47	0.25	0.78	0.29	0.84	0.62	0.93	0.84		0.31	-0.53	0.8
Short Term Debt	0.24	0.15	0.61	0.77	-0.01	0.23	-0.32	-0.17	-0.1	0.69	0.35	-0.42	-0.4	0.26	0.23	-0.22	0.35	0.56	0.14	0.47	0.24	0.29	0.31		0.34	-0.14
Intangible Assets	-0.62	-0.48	0.2	0.3	-0.67	-0.49	-0.28	0.04	0.44	0.61	-0.45	-0.28	-0.66	-0.59	0.62	-0.55	-0.16	0.43	-0.34	-0.12	-0.46	-0.2	-0.53	0.34		-0.84
Common Stock	0.87	0.72	0.02	0.02	0.66	0.76	-0.05	0.15	-0.73	-0.22	0.66	0.2	0.79	0.83	-0.67	0.42	0.42	-0.27	0.61	0.4	0.74	0.51	0.8	-0.14	-0.84

Click cells to compare fundamentals

Journey Medical Account Relationship Matchups

Journey Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.9M	51.9M	97.3M	105.2M	76.8M	73.0M
Short Long Term Debt Total	5.3M	5.4M	910K	23.0M	17.7M	16.8M
Other Current Liab	18.8M	26.0M	23.4M	26.8M	20.6M	25.8M
Total Current Liabilities	20.9M	28.1M	51.6M	66.8M	41.9M	46.9M
Total Stockholder Equity	2.8M	10.3M	42.0M	17.0M	20.4M	19.3M
Property Plant And Equipment Net	1.2M	89K	175K	189K	101K	96.0K
Net Debt	502K	(2.8M)	(48.2M)	(9.0M)	(9.7M)	(10.2M)
Retained Earnings	(163K)	5.1M	(38.9M)	(68.5M)	(72.4M)	(76.0M)
Accounts Payable	2.0M	2.0M	22.8M	37.0M	18.1M	15.5M
Cash	4.8M	8.2M	49.1M	32.0M	27.4M	26.1M
Non Current Assets Total	8.6M	16.7M	12.8M	27.5M	20.4M	16.4M
Non Currrent Assets Other	656K	3.0M	6K	150K	95K	5.7K
Cash And Short Term Investments	4.8M	8.2M	49.1M	32.0M	27.4M	26.1M
Net Receivables	19.0M	23.9M	23.1M	28.2M	15.2M	17.6M
Liabilities And Stockholders Equity	33.9M	51.9M	97.3M	105.2M	76.8M	73.0M
Non Current Liabilities Total	10.2M	13.6M	3.6M	21.3M	14.6M	13.9M
Other Current Assets	655K	1.7M	4.9M	3.3M	3.6M	3.4M
Other Stockholder Equity	2.9M	5.2M	80.9M	85.5M	92.7M	88.1M
Total Liab	31.1M	41.6M	55.2M	88.2M	56.5M	93.1M
Total Current Assets	25.3M	35.2M	84.5M	77.7M	56.5M	53.6M
Intangible Assets	7.4M	15.0M	12.6M	27.2M	20.3M	21.3M
Inventory	857K	1.4M	9.9M	14.2M	10.2M	8.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:

How To Invest In Journey

Details

Is Journey Stock a good investment?

Details

What is Journey Medical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.92)

Revenue Per Share

2.921

Quarterly Revenue Growth

(0.58)

Return On Assets

(0.17)

Return On Equity

(1.30)

The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Journey Free Cash Flow Per Share vs Ev To Sales Analysis

Free Cash Flow Per Share vs Ev To Sales

Free Cash Flow Per Share vs Ev To Sales Correlation Analysis

Correlation Coefficient

Free Cash Flow Per Share

Ev To Sales

Journey Medical fundamental ratios Correlations

Journey Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Journey Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.98	Total Assets
Total Liab	+ 0.98	Non Current Liabilities Total
Other Stockholder Equity	+ 0.96	Property Plant And Equipment Net
Other Stockholder Equity	+ 0.95	Short Long Term Debt Total

Non Current Liabilities Total	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Total Liab	- 0.91	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Short Term Investments	- 0.88	Non Current Assets Total
Total Current Assets	- 0.87	Retained Earnings